The Adverse Event Reporting System (AERS) is a computerized information database designed to support the FDA's post-marketing safety surveillance program for all approved drug and therapeutic biologic products. Submissions to the database are voluntary as they ...
CITATION STYLE
Mitchell, M. A., & Barratt, M. J. (2012). Appendix: Additional Drug Repositioning Resources and Links. In Drug Repositioning (pp. 457–468). Wiley. https://doi.org/10.1002/9781118274408.app1
Mendeley helps you to discover research relevant for your work.